These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29611459)

  • 41. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relapse prevention in schizophrenia: attitudes of neurologists-psychiatrists.
    Bergiannaki JD; Hatzimanolis J; Liappas J; Sakkas PN; Stefanis CN
    Eur Psychiatry; 2001 Mar; 16(2):90-8. PubMed ID: 11311172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical variables influencing treatment decisions for agitated dementia patients: survey of physician judgments.
    Colenda CC; Rapp SR; Leist JC; Poses RM
    J Am Geriatr Soc; 1996 Nov; 44(11):1375-9. PubMed ID: 8909356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.
    Johnson FR; Ozdemir S; Mansfield C; Hass S; Miller DW; Siegel CA; Sands BE
    Gastroenterology; 2007 Sep; 133(3):769-79. PubMed ID: 17628557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment.
    Hamann J; Mendel RT; Fink B; Pfeiffer H; Cohen R; Kissling W
    J Nerv Ment Dis; 2008 Apr; 196(4):329-32. PubMed ID: 18414128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Why do physicians switch from one antipsychotic agent to another? The "physician drug stereotype".
    Linden M; Pyrkosch L; Dittmann RW; Czekalla J
    J Clin Psychopharmacol; 2006 Jun; 26(3):225-31. PubMed ID: 16702886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influences on therapist's decisions for neuroleptic treatment in schizophrenia: the role of characteristics of the patient and the physician.
    Franz M; Ranger J; Hanewald B; Gallhofer B; Lay B
    Pharmacopsychiatry; 2012 Nov; 45(7):261-8. PubMed ID: 22648306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A closer look at decision and analyst error by including nonlinearities in discrete choice models: implications on willingness-to-pay estimates derived from discrete choice data in healthcare.
    de Bekker-Grob EW; Rose JM; Bliemer MC
    Pharmacoeconomics; 2013 Dec; 31(12):1169-83. PubMed ID: 24178372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring.
    Best-Shaw L; Gudbrandsen M; Nagar J; Rose D; David AS; Patel MX
    Ther Drug Monit; 2014 Aug; 36(4):486-93. PubMed ID: 24384695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional survey.
    Lecrubier Y; Perry R; Milligan G; Leeuwenkamp O; Morlock R
    Eur Psychiatry; 2007 Sep; 22(6):371-9. PubMed ID: 17521890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychiatrists' psychotropic drug prescription preferences for themselves or their family members.
    Latas M; Stojkovic T; Ralic T; Milovanovic S; Jasovic-Gasic M
    Psychiatr Danub; 2012 Jun; 24(2):182-7. PubMed ID: 22706417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Personalizing Medical Treatment Decisions: Integrating Meta-analytic Treatment Comparisons with Patient-Specific Risks and Preferences.
    Weyant C; Brandeau ML; Basu S
    Med Decis Making; 2019 Nov; 39(8):998-1009. PubMed ID: 31707910
    [No Abstract]   [Full Text] [Related]  

  • 54. Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China.
    Mohamed S; Rosenheck R; He H; Yuping N
    Soc Psychiatry Psychiatr Epidemiol; 2014 Jul; 49(7):1063-70. PubMed ID: 24549835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms.
    Reed SD; Fairchild AO; Johnson FR; Gonzalez JM; Mentz RJ; Krucoff MW; Vemulapalli S
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008051. PubMed ID: 31752516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment effectiveness in patients with schizophrenia as measured by the ASSESS battery - first longitudinal data.
    Ladea M; Barbu CM; Juckel G
    Psychiatr Danub; 2015 Dec; 27(4):364-70. PubMed ID: 26609648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.
    Harvey RC; James AC; Shields GE
    CNS Drugs; 2016 Jan; 30(1):27-39. PubMed ID: 26801655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors Associated with Management of Teen Aggression: Child Psychiatric Clinical Decision Making.
    Mann A; Li A; Radwan K; Karnik NS; Keenan K
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):445-450. PubMed ID: 26784955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current practice and tolerance for risk in performing procedural sedation and analgesia on children who have not met fasting guidelines: a Canadian survey using a stated preference discrete choice experiment.
    Bhatt M; Currie GR; Auld MC; Johnson DW
    Acad Emerg Med; 2010 Nov; 17(11):1207-15. PubMed ID: 21175519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve Replacement.
    Hussain AI; Garratt AM; Brunborg C; Aakhus S; Gullestad L; Pettersen KI
    J Am Heart Assoc; 2016 Mar; 5(3):e002828. PubMed ID: 26994130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.